<DOC>
	<DOC>NCT00632450</DOC>
	<brief_summary>The EnSite Real-Time Cardiac Performance Measurements Study (EnSite RT CPM) is a multicenter, international, acute, non-significant risk study, designed to enroll a maximum of 40 patient. The goal of the study is to collect 3-D systolic/diastolic data with the EnSite NavX Mapping system during a CRT implant. Patients enrolled in this study will undergo NavX CPM recording of the heart using the EnSite NavX Mapping system during the implantation of a cardiac resynchronization therapy device.</brief_summary>
	<brief_title>EnSite Real-Time Cardiac Performance Measurements (RT CPM) Study</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Be undergoing a new St. Jude Medical CRTD or CRTP device implantation Have the ability to provide informed consent for study participation and be willing to comply with the prescribed perioperative evaluations Have a recent myocardial infarction within 40 days prior to enrollment Have undergone cardiac surgery or coronary revascularization procedure within 3 months prior to enrollment or be scheduled for such procedures Be less than 18 years of age Be pregnant women Be currently participating in a clinical study that includes an active treatment arm</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
</DOC>